Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort-Reference-Cited by-同舟云学术

Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort

Published:2017-09-21 Issue:2 Volume:25 Page:187-197
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Serper M.¹²³,Forde K. A.³⁴,Kaplan D. E.¹³^ORCID

Affiliation:

1. Gastroenterology Section; Corporal Michael J. Crescenz VA Medical Center; Philadelphia PA USA

2. Center for Health Equity Research and Promotion; Corporal Michael J. Crescenz VA Medical Center; Philadelphia PA USA

3. Division of Gastroenterology; Department of Medicine; Hospital of the University of Pennsylvania; Philadelphia PA USA

4. Center for Clinical Epidemiology and Biostatistics; Perelman School of Medicine at the University of Pennsylvania; Philadelphia PA USA

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12784/fullpdf

Reference23 articles.

1. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B;Crespo;Am J Gastroenterol,1994

2. Multiple viral hepatitis in injection drug users and associated risk factors;Reimer;J Gastroenterol Hepatol,2007

3. Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma;De Mitri;Liver Int,2007

4. Treatment of HBV/HCV coinfection;Potthoff;Expert Opin Pharmacother,2010

5. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells;Eyre;J Hepatol,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C infection;Treatment and Management of Tropical Liver Disease;2025

2. Hepatitis B virus coinfection in patients treated for chronic hepatitis C: Clinical characteristics, risk of reactivation with long-term follow-up and effectiveness of antiviral therapy;Polish Archives of Internal Medicine;2024-01-02

3. Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023;MMWR. Recommendations and Reports;2023-03-10

4. Treatment Recommendations for Harder-to-Cure and Vulnerable Populations;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01

5. Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy;Journal of Clinical Medicine;2022-03-04